Rosuvastatin clinical uses
Pro Research Analysisby 
Searched over 200M research papers
Rosuvastatin Clinical Uses: Lipid-Lowering and Cardiovascular Disease Prevention
Rosuvastatin for Dyslipidemia and Hypercholesterolemia
Rosuvastatin is a highly effective statin used to treat dyslipidemia and primary hypercholesterolemia. It significantly lowers low-density lipoprotein cholesterol (LDL-C) by 34–65% across a range of doses, with a typical starting dose of 10 mg reducing LDL-C by about 50%—enough to help most patients reach recommended cholesterol targets. Rosuvastatin also increases high-density lipoprotein cholesterol (HDL-C) and is more potent than atorvastatin in lowering LDL-C, making it a preferred choice for many patients with high cholesterol or at risk for cardiovascular disease 129.
Rosuvastatin in Cardiovascular Disease Prevention
Rosuvastatin is widely used for both primary and secondary prevention of cardiovascular events. Its benefits extend beyond cholesterol lowering, as it also has anti-inflammatory, antioxidant, and antithrombotic effects. These properties make it a crucial tool in reducing the risk of heart attacks, strokes, and other cardiovascular complications in at-risk individuals 24.
Stroke Prevention with Rosuvastatin
Clinical trials have shown that rosuvastatin can reduce the risk of stroke, particularly ischemic stroke, by more than half in people with low LDL-C but elevated C-reactive protein levels. This effect is consistent across different patient groups, highlighting rosuvastatin’s role in stroke prevention for those with increased cardiovascular risk .
Rosuvastatin for Venous Thromboembolism (VTE) and Coagulation
Rosuvastatin has been shown to improve coagulation profiles and increase plasma fibrinolytic potential in patients with a history of venous thromboembolism (VTE). It lowers levels of several coagulation factors and enhances the body’s ability to break down clots, suggesting a possible role in the secondary prevention of VTE 58.
Rosuvastatin in Metabolic Associated Fatty Liver Disease (MAFLD)
Recent studies indicate that rosuvastatin can significantly reduce liver fat content in patients with moderate to severe metabolic associated fatty liver disease (MAFLD) and metabolic syndrome, without causing significant safety concerns. This suggests a potential benefit for patients with fatty liver disease who also have dyslipidemia or metabolic syndrome .
Combination Therapy: Rosuvastatin/Ezetimibe
Rosuvastatin is also available in combination with ezetimibe, which further enhances cholesterol lowering by inhibiting intestinal cholesterol absorption. This fixed-dose combination is more effective than rosuvastatin alone in reducing LDL-C and helps more patients achieve their cholesterol goals, with a similar safety profile .
Effects on Atherosclerotic Plaque and Subclinical Atherosclerosis
Rosuvastatin reduces active microcalcification in atherosclerotic plaques, as shown by imaging studies. This effect may contribute to plaque stabilization and reduced risk of cardiovascular events in high-risk individuals with subclinical atherosclerosis .
Conclusion
Rosuvastatin is a potent and versatile statin used primarily for lowering cholesterol and preventing cardiovascular disease. Its clinical uses include treating dyslipidemia, reducing the risk of heart attack and stroke, improving coagulation in VTE patients, reducing liver fat in MAFLD, and stabilizing atherosclerotic plaques. It is effective both as monotherapy and in combination with ezetimibe, offering a broad range of benefits for patients at risk of cardiovascular and metabolic diseases 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic